Bicycle Therapeutics (BCYC) Gains from Investment Securities (2018 - 2025)
Historic Gains from Investment Securities for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $233000.0.
- Bicycle Therapeutics' Gains from Investment Securities fell 2483.87% to $233000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year decrease of 8600000.0%. This contributed to the annual value of -$1.5 million for FY2024, which is 13730.12% down from last year.
- As of Q3 2025, Bicycle Therapeutics' Gains from Investment Securities stood at $233000.0, which was down 2483.87% from -$1.2 million recorded in Q2 2025.
- Bicycle Therapeutics' Gains from Investment Securities' 5-year high stood at $13.8 million during Q4 2021, with a 5-year trough of -$2.6 million in Q4 2024.
- In the last 5 years, Bicycle Therapeutics' Gains from Investment Securities had a median value of $310000.0 in 2024 and averaged $2.5 million.
- As far as peak fluctuations go, Bicycle Therapeutics' Gains from Investment Securities skyrocketed by 1353636.36% in 2021, and later crashed by 45961.54% in 2025.
- Quarter analysis of 5 years shows Bicycle Therapeutics' Gains from Investment Securities stood at $13.8 million in 2021, then crashed by 77.32% to $3.1 million in 2022, then crashed by 103.4% to -$106000.0 in 2023, then crashed by 2311.32% to -$2.6 million in 2024, then surged by 109.12% to $233000.0 in 2025.
- Its last three reported values are $233000.0 in Q3 2025, -$1.2 million for Q2 2025, and $43000.0 during Q1 2025.